Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-α inhibitors.
Palacios-Diaz RD, Sahuquillo-Torralba A, Rocamora-Durán V, Unamuno-Bustos B, Salavert-Lleti M, Santos-Alarcón S, Quintero A, Garcías-Ladaria J, Vila-Payeras A, Martínez-Doménech A, Mateu-Puchades A, Nadal-Lladó C, Botella-Estrada R.
Palacios-Diaz RD, et al. Among authors: garcias ladaria j.
J Dtsch Dermatol Ges. 2023 May;21(5):473-480. doi: 10.1111/ddg.15007. Epub 2023 Apr 12.
J Dtsch Dermatol Ges. 2023.
PMID: 37042124